Sight Sciences Stock Today

SGHT Stock  USD 3.50  0.04  1.16%   

Performance

Weakest

 
Weak
 
Strong

Odds Of Distress

Strong

 
High
 
Low
Sight Sciences is selling for under 3.50 as of the 15th of September 2025; that is 1.16 percent increase since the beginning of the trading day. The stock's last reported lowest price was 3.45. Sight Sciences has a very high chance of experiencing financial distress in the next few years of operation. It has also generated negative returns for investors over the last 90 days. The performance scores are derived for the period starting the 16th of August 2025 and ending today, the 15th of September 2025. Click here to learn more.
Business Domain
Health Care Equipment & Services
IPO Date
15th of July 2021
Category
Healthcare
Classification
Health Care
Sight Sciences, Inc., an ophthalmic medical device company, engages in the development and commercialization of surgical and nonsurgical technologies for the treatment of eye diseases. The company was incorporated in 2010 and is headquartered in Menlo Park, California. The company has 52.37 M outstanding shares of which 1.04 M shares are at this time shorted by private and institutional investors with about 8.2 trading days to cover. More on Sight Sciences

Moving against Sight Stock

  0.43AHG Akso Health Group Earnings Call This WeekPairCorr
  0.33LNSR LENSAR IncPairCorr
Follow Valuation Options Odds of Bankruptcy
Check how we calculate scores

Sight Stock Highlights

ESG Sustainability
Environmental
Governance
Social
Business ConcentrationHealth Care Equipment & Supplies, Health Care Equipment & Services, Health Care, NASDAQ Composite, NASDAQ Health Care, Health Care, Health Care Equipment & Supplies, Medical Devices, Healthcare (View all Sectors)
Average Analyst Recommendation
Financial Strength
Current ValueLast YearChange From Last Year 10 Year Trend
Asset Turnover0.570.5591
Fairly Up
Slightly volatile
Gross Profit Margin0.620.855
Way Down
Slightly volatile
Total Current Liabilities12.3 M15.5 M
Significantly Down
Slightly volatile
Non Current Liabilities Total46.7 M39.8 M
Fairly Up
Pretty Stable
Total Assets143.7 M142.8 M
Slightly Up
Slightly volatile
Total Current Assets140.7 M139.8 M
Slightly Up
Slightly volatile
Debt Levels
Sight Sciences can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Sight Sciences' financial leverage. It provides some insight into what part of Sight Sciences' total assets is financed by creditors.
Liquidity
Sight Sciences currently holds 40.36 M in liabilities with Debt to Equity (D/E) ratio of 0.18, which may suggest the company is not taking enough advantage from borrowing. Sight Sciences has a current ratio of 16.4, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about Sight Sciences' use of debt, we should always consider it together with its cash and equity.

Other Cashflows From Financing Activities

(247,950)
Sight Sciences (SGHT) is traded on NASDAQ Exchange in USA. It is located in 4040 Campbell Avenue, Menlo Park, CA, United States, 94025 and employs 216 people. Sight Sciences is listed under Health Care Equipment & Supplies category by Fama And French industry classification. The company currently falls under 'Small-Cap' category with a current market capitalization of 181.19 M. Sight Sciences conducts business under Health Care Equipment & Supplies sector and is part of Health Care industry. The entity has 52.37 M outstanding shares of which 1.04 M shares are at this time shorted by private and institutional investors with about 8.2 trading days to cover. Sight Sciences currently holds about 220.1 M in cash with (22.35 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.6, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check Sight Sciences Probability Of Bankruptcy
Ownership Allocation
Sight Sciences shows a total of 52.37 Million outstanding shares. Over half of Sight Sciences' outstanding shares are owned by institutional holders. These institutional holders are typically referred to as corporate investors that take positions in a given instrument to benefit from reduced trade commissions. Please note that no matter how many assets the company owns, if the real value of the company is less than the current market value, you may not be able to make money on it.
Check Sight Ownership Details

Sight Stock Institutional Holders

InstituionRecorded OnShares
Northern Trust Corp2025-06-30
340.4 K
Morgan Stanley - Brokerage Accounts2025-06-30
333.4 K
Dimensional Fund Advisors, Inc.2025-06-30
300.6 K
Charles Schwab Investment Management Inc2025-06-30
266.3 K
D. E. Shaw & Co Lp2025-06-30
253.8 K
Gotham Asset Management, Llc2025-06-30
156.5 K
Jpmorgan Chase & Co2025-06-30
133.7 K
Bank Of America Corp2025-06-30
105.7 K
Bridgeway Capital Management, Llc2025-06-30
96.4 K
Kck Ltd2025-06-30
4.4 M
Long Focus Capital Management, Llc2025-06-30
3.2 M
View Sight Sciences Diagnostics

Sight Sciences Historical Income Statement

At this time, Sight Sciences' Tax Provision is comparatively stable compared to the past year. Depreciation And Amortization is likely to gain to about 758.7 K in 2025, whereas Selling General Administrative is likely to drop slightly above 75.9 M in 2025. View More Fundamentals

Sight Stock Against Markets

Sight Sciences Corporate Management

Additional Tools for Sight Stock Analysis

When running Sight Sciences' price analysis, check to measure Sight Sciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sight Sciences is operating at the current time. Most of Sight Sciences' value examination focuses on studying past and present price action to predict the probability of Sight Sciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sight Sciences' price. Additionally, you may evaluate how the addition of Sight Sciences to your portfolios can decrease your overall portfolio volatility.